• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global heparin market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global heparin market 2018 – 2022 ($ billion)
o 4.2 Product Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
o 4.3 Route Of Administration Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Route Of Administration Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product – Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Low-molecular-weight heparin – Market size and forecast 2023-2028
o Exhibit 34: Chart on Low-molecular-weight heparin – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Low-molecular-weight heparin – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Low-molecular-weight heparin – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Low-molecular-weight heparin – Year-over-year growth 2023-2028 (%)
o 6.4 Others – Market size and forecast 2023-2028
o Exhibit 38: Chart on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ billion)
o Exhibit 43: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 44: Chart on Route of Administration – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Route of Administration – Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 46: Chart on Comparison by Route of Administration
o Exhibit 47: Data Table on Comparison by Route of Administration
o 7.3 Subcutaneous injection – Market size and forecast 2023-2028
o Exhibit 48: Chart on Subcutaneous injection – Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Subcutaneous injection – Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Subcutaneous injection – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Subcutaneous injection – Year-over-year growth 2023-2028 (%)
o 7.4 Intravenous infusion – Market size and forecast 2023-2028
o Exhibit 52: Chart on Intravenous infusion – Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Intravenous infusion – Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Intravenous infusion – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Intravenous infusion – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 56: Market opportunity by Route of Administration ($ billion)
o Exhibit 57: Data Table on Market opportunity by Route of Administration ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 Europe – Market size and forecast 2023-2028
o Exhibit 63: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 64: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.4 North America – Market size and forecast 2023-2028
o Exhibit 67: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 79: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 UK – Market size and forecast 2023-2028
o Exhibit 83: Chart on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 China – Market size and forecast 2023-2028
o Exhibit 91: Chart on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.11 France – Market size and forecast 2023-2028
o Exhibit 95: Chart on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Aspen Pharmacare Holdings Ltd
o Exhibit 107: Aspen Pharmacare Holdings Ltd – Overview
o Exhibit 108: Aspen Pharmacare Holdings Ltd – Business segments
o Exhibit 109: Aspen Pharmacare Holdings Ltd – Key offerings
o Exhibit 110: Aspen Pharmacare Holdings Ltd – Segment focus
o 12.4 B.Braun SE
o Exhibit 111: B.Braun SE – Overview
o Exhibit 112: B.Braun SE – Business segments
o Exhibit 113: B.Braun SE – Key news
o Exhibit 114: B.Braun SE – Key offerings
o Exhibit 115: B.Braun SE – Segment focus
o 12.5 Baxter International Inc.
o Exhibit 116: Baxter International Inc. – Overview
o Exhibit 117: Baxter International Inc. – Business segments
o Exhibit 118: Baxter International Inc. – Key news
o Exhibit 119: Baxter International Inc. – Key offerings
o Exhibit 120: Baxter International Inc. – Segment focus
o 12.6 Eisai Co. Ltd.
o Exhibit 121: Eisai Co. Ltd. – Overview
o Exhibit 122: Eisai Co. Ltd. – Business segments
o Exhibit 123: Eisai Co. Ltd. – Key offerings
o Exhibit 124: Eisai Co. Ltd. – Segment focus
o 12.7 Fresenius SE and Co. KGaA
o Exhibit 125: Fresenius SE and Co. KGaA – Overview
o Exhibit 126: Fresenius SE and Co. KGaA – Business segments
o Exhibit 127: Fresenius SE and Co. KGaA – Key news
o Exhibit 128: Fresenius SE and Co. KGaA – Key offerings
o Exhibit 129: Fresenius SE and Co. KGaA – Segment focus
o 12.8 Hikma Pharmaceuticals Plc
o Exhibit 130: Hikma Pharmaceuticals Plc – Overview
o Exhibit 131: Hikma Pharmaceuticals Plc – Business segments
o Exhibit 132: Hikma Pharmaceuticals Plc – Key offerings
o Exhibit 133: Hikma Pharmaceuticals Plc – Segment focus
o 12.9 Laboratorios Farmaceuticos ROVI S A
o Exhibit 134: Laboratorios Farmaceuticos ROVI S A – Overview
o Exhibit 135: Laboratorios Farmaceuticos ROVI S A – Business segments
o Exhibit 136: Laboratorios Farmaceuticos ROVI S A – Key offerings
o Exhibit 137: Laboratorios Farmaceuticos ROVI S A – Segment focus
o 12.10 Nanjing Kingfriend Biochemical
o Exhibit 138: Nanjing Kingfriend Biochemical – Overview
o Exhibit 139: Nanjing Kingfriend Biochemical – Product / Service
o Exhibit 140: Nanjing Kingfriend Biochemical – Key offerings
o 12.11 Nichi Iko Pharmaceutical Co. Ltd.
o Exhibit 141: Nichi Iko Pharmaceutical Co. Ltd. – Overview
o Exhibit 142: Nichi Iko Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 143: Nichi Iko Pharmaceutical Co. Ltd. – Key offerings
o 12.12 Novartis AG
o Exhibit 144: Novartis AG – Overview
o Exhibit 145: Novartis AG – Business segments
o Exhibit 146: Novartis AG – Key offerings
o Exhibit 147: Novartis AG – Segment focus
o 12.13 Pfizer Inc.
o Exhibit 148: Pfizer Inc. – Overview
o Exhibit 149: Pfizer Inc. – Product / Service
o Exhibit 150: Pfizer Inc. – Key news
o Exhibit 151: Pfizer Inc. – Key offerings
o 12.14 Sanofi SA
o Exhibit 152: Sanofi SA – Overview
o Exhibit 153: Sanofi SA – Business segments
o Exhibit 154: Sanofi SA – Key news
o Exhibit 155: Sanofi SA – Key offerings
o Exhibit 156: Sanofi SA – Segment focus
o 12.15 Shenzhen Techdow Pharmaceutical
o Exhibit 157: Shenzhen Techdow Pharmaceutical – Overview
o Exhibit 158: Shenzhen Techdow Pharmaceutical – Product / Service
o Exhibit 159: Shenzhen Techdow Pharmaceutical – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 162: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 163: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 164: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 165: Viatris Inc. – Overview
o Exhibit 166: Viatris Inc. – Business segments
o Exhibit 167: Viatris Inc. – Key news
o Exhibit 168: Viatris Inc. – Key offerings
o Exhibit 169: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global heparin market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – Route Of Administration Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Product – Market share 2023-2028 (%)
Exhibits31: Data Table on Product – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Low-molecular-weight heparin – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Low-molecular-weight heparin – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Low-molecular-weight heparin – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Low-molecular-weight heparin – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Data Table on Market opportunity by Product ($ billion)
Exhibits44: Chart on Route of Administration – Market share 2023-2028 (%)
Exhibits45: Data Table on Route of Administration – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Route of Administration
Exhibits47: Data Table on Comparison by Route of Administration
Exhibits48: Chart on Subcutaneous injection – Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Subcutaneous injection – Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Subcutaneous injection – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Subcutaneous injection – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Intravenous infusion – Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Intravenous infusion – Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Intravenous infusion – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Intravenous infusion – Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Route of Administration ($ billion)
Exhibits57: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on France – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on France – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Aspen Pharmacare Holdings Ltd – Overview
Exhibits108: Aspen Pharmacare Holdings Ltd – Business segments
Exhibits109: Aspen Pharmacare Holdings Ltd – Key offerings
Exhibits110: Aspen Pharmacare Holdings Ltd – Segment focus
Exhibits111: B.Braun SE – Overview
Exhibits112: B.Braun SE – Business segments
Exhibits113: B.Braun SE – Key news
Exhibits114: B.Braun SE – Key offerings
Exhibits115: B.Braun SE – Segment focus
Exhibits116: Baxter International Inc. – Overview
Exhibits117: Baxter International Inc. – Business segments
Exhibits118: Baxter International Inc. – Key news
Exhibits119: Baxter International Inc. – Key offerings
Exhibits120: Baxter International Inc. – Segment focus
Exhibits121: Eisai Co. Ltd. – Overview
Exhibits122: Eisai Co. Ltd. – Business segments
Exhibits123: Eisai Co. Ltd. – Key offerings
Exhibits124: Eisai Co. Ltd. – Segment focus
Exhibits125: Fresenius SE and Co. KGaA – Overview
Exhibits126: Fresenius SE and Co. KGaA – Business segments
Exhibits127: Fresenius SE and Co. KGaA – Key news
Exhibits128: Fresenius SE and Co. KGaA – Key offerings
Exhibits129: Fresenius SE and Co. KGaA – Segment focus
Exhibits130: Hikma Pharmaceuticals Plc – Overview
Exhibits131: Hikma Pharmaceuticals Plc – Business segments
Exhibits132: Hikma Pharmaceuticals Plc – Key offerings
Exhibits133: Hikma Pharmaceuticals Plc – Segment focus
Exhibits134: Laboratorios Farmaceuticos ROVI S A – Overview
Exhibits135: Laboratorios Farmaceuticos ROVI S A – Business segments
Exhibits136: Laboratorios Farmaceuticos ROVI S A – Key offerings
Exhibits137: Laboratorios Farmaceuticos ROVI S A – Segment focus
Exhibits138: Nanjing Kingfriend Biochemical – Overview
Exhibits139: Nanjing Kingfriend Biochemical – Product / Service
Exhibits140: Nanjing Kingfriend Biochemical – Key offerings
Exhibits141: Nichi Iko Pharmaceutical Co. Ltd. – Overview
Exhibits142: Nichi Iko Pharmaceutical Co. Ltd. – Product / Service
Exhibits143: Nichi Iko Pharmaceutical Co. Ltd. – Key offerings
Exhibits144: Novartis AG – Overview
Exhibits145: Novartis AG – Business segments
Exhibits146: Novartis AG – Key offerings
Exhibits147: Novartis AG – Segment focus
Exhibits148: Pfizer Inc. – Overview
Exhibits149: Pfizer Inc. – Product / Service
Exhibits150: Pfizer Inc. – Key news
Exhibits151: Pfizer Inc. – Key offerings
Exhibits152: Sanofi SA – Overview
Exhibits153: Sanofi SA – Business segments
Exhibits154: Sanofi SA – Key news
Exhibits155: Sanofi SA – Key offerings
Exhibits156: Sanofi SA – Segment focus
Exhibits157: Shenzhen Techdow Pharmaceutical – Overview
Exhibits158: Shenzhen Techdow Pharmaceutical – Product / Service
Exhibits159: Shenzhen Techdow Pharmaceutical – Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits165: Viatris Inc. – Overview
Exhibits166: Viatris Inc. – Business segments
Exhibits167: Viatris Inc. – Key news
Exhibits168: Viatris Inc. – Key offerings
Exhibits169: Viatris Inc. – Segment focus
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations